CLADRIBINE

Generic: CLADRIBINE

Apotex Corp.Manufacturer
ORALRoute
CLADRIBINEActive Substance
2025-11-24Original Approval

CLADRIBINE is FDA application ANDA218425, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
OFF LABEL USE
311 reports
2
DRUG INEFFECTIVE
225 reports
3
FEBRILE NEUTROPENIA
211 reports
4
PYREXIA
191 reports
5
NEUTROPENIA
155 reports
6
PANCYTOPENIA
151 reports
7
THROMBOCYTOPENIA
127 reports
8
PRODUCT USE IN UNAPPROVED INDICATION
122 reports
9
PNEUMONIA
109 reports
10
RASH MACULO-PAPULAR
94 reports